Enhanced Natural Killers with CISH and B2M Gene Knockouts Reveal Increased Cytotoxicity in Glioblastoma Primary Cultures

In an experimental study using the CRISPR/Cas9 system, “enhanced” NK cell lines with knockout of CISH , the gene for the CIS protein (a negative regulator of NK cytotoxicity), as well as two lines with a knocked-out β2-microglobulin gene, which provides membrane exposure of MHC class I, were obtaine...

Full description

Saved in:
Bibliographic Details
Published in:Molecular biology (New York) Vol. 56; no. 5; pp. 770 - 779
Main Authors: Yusubalieva, G. M., Dashinimaev, E. B., Gorchakov, A. A., Kulemzin, S. V., Brovkina, O. A., Kalinkin, A. A., Vinokurov, A. G., Shirmanova, M. V., Taranin, A. V., Baklaushev, V. P.
Format: Journal Article
Language:English
Published: Moscow Pleiades Publishing 01-10-2022
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In an experimental study using the CRISPR/Cas9 system, “enhanced” NK cell lines with knockout of CISH , the gene for the CIS protein (a negative regulator of NK cytotoxicity), as well as two lines with a knocked-out β2-microglobulin gene, which provides membrane exposure of MHC class I, were obtained from two parental lines of human natural killers (YT wild type and YT-VAV1 + overexpressing the VAV1 cytotoxicity enhancing protein). The knockout efficiency was determined by real-time PCR as well as by flow cytometry with specific antibodies. The resulting CISH –/– or B2M –/– knockout lines were tested for cytotoxicity in primary monolayer cultures of human glioblastoma multiforme. The cytotoxicity of the lines was assessed using a cell analyzer that records the cell index based on cell impedance. YT-CISH –/– has been shown to be significantly more effective than wild-type YT in eliminating primary glioblastoma cells in an in vitro cell monolayer experiment. The cytotoxicity of the YT-VAV1 + -CISH –/– and YT-VAV1 + B2M –/– lines against glioblastoma cells was the highest, but overall, it did not significantly differ from the initially increased cytotoxicity of the YT-VAV1 + line. The lines of NK-like cells obtained may serve as a prototype for the creation of “enhanced” allogeneic and autologous NK- and CAR-NK cells for the immunotherapy of glioblastoma multiforme.
ISSN:0026-8933
1608-3245
DOI:10.1134/S0026893322050156